Rhein Biotech has developed technologies and industrial manufacturing processes for a number of marketed products which include:
We have out-licensed these products to our partners, transferring the production technologies for implementation at their manufacturing facilities. In addition, we have supported the development and GMP manufacturing of several product candidates that are currently in clinical development or close to registration.
We have developed manufacturing processes for multiple subtypes of hepatitis B virus antigens for clinical and commercial use. For the diagnostic market, we have used our vaccine production technologies to manufacture recombinant antigens and have supply agreements with several international diagnostic companies. Several additional viral antigens are available on request.
For additional information, please contact us at bd(at)rheinbiotech.de
Rhein Biotech GmbH
Dynavax Europe
Eichsfelder Strasse 11
D-40595 Düsseldorf
Phone: +49 (0)211 7 58 45 0
Fax: +49 (0)211 7 58 45 130
E-Mail: info(at)rheinbiotech.de
Print page 
